Arrhythmias, Cardiac

10 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Cardiovascular Diseases, Heart Diseases

Narrower: Atrial Fibrillation 7, Tachycardia, Ventricular 1, Ventricular Fibrillation 1

Treatments and conditions

Arrhythmias, Cardiac
Treatment and conditionWhere it standsTrials
Amrecibart for atrial fibrillationPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Cenvacibart for atrial fibrillationPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Echocardiography + Electrocardiogram (ECG) + DEFERIPRONE + Deferoxamine + Deferasirox for arrhythmias, cardiacPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Finerenone for atrial fibrillationPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
L-PSGB first for tachycardia, ventricularTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
L-PSGB first for ventricular fibrillationTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Medical or interventional therapy for rhythm control in atrial fibrillation (antiarrhythmic drugs, ablation, electric cardio version) for atrial fibrillationPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
pharmacogenetic algorithm for atrial fibrillationPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Prasugrel or Ticagrelor for atrial fibrillationPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Semaglutide for atrial fibrillationPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.